IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Molecular cancer therapeutics Joan Albanell

The objective of the group is to contribute to improving cancer treatment through preclinical research on in vitro and ex vivo models, biomarker studies for predicting responses and pharmacodynamics and clinical trials.

The group is led by Dr. Joan Albanell, Director of the Medical Oncology Service at the Hospital del Mar, and the recipient of a grant for research intensification.

Dr. Albanell has made numerous contributions to clinical and translational research in oncology, which he performed at the Hospitals Memorial Sloan-Kettering Cancer Centre (1995-96), the Hospitals de la Vall d’Hebron (1997-2002) and Hospital Clínic (2002-June 2005). He is a member of the Board of Directors of ASEICA (Spanish Association of Research against Cancer), of GEICAM (Spanish Breast Cancer Research Group) and SEOM (Spanish Society of Medical Oncology).

The group, made up of oncologists, pathologists and biologists, is part of the CIBERONC consortium, the Center for Biomedical Research in Red Cancer, and is a group recognized as a group consolidated by the AGAUR, the Agency for Management of University an Research Grants.

It is structured in five laboratories or research areas:

  • Research in breast cancer, led by Dr. Joan Albanell
  • Research on the properties of cancer stem cells and metastasis, led by Dr. Toni Celià-Terrassa
  • Research in colorectal cancer, led by Dr. Clara Montagut
  • Research in colorectal cancer, led by Dr. Alexandre Calon
  • Research in lung cancer, led by Dr. Edurne Arriola

Contact

Coordinator:
Joan Albanell(ELIMINAR)

Tel:
93 248 31 37

Fax:
93 248 33 66

Pg Marítim, 25-29
08003 Barcelona

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact